CX Institutional
INSM icon

CX Institutional’s Insmed INSM Stock Holding History

CX Institutional’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$46K Buy
+404
New +$47.6K ﹤0.01% 1028
2026
Q2 		– Sell
-150
Closed -$25K – 1611
2026
Q1 		$25K Buy
+150
New +$23.1K ﹤0.01% 1085

Other funds holding INSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Axxion S.A.
Axxion S.A. Grevenmacher, Luxembourg $1.52B AUM
McRae Capital Management
McRae Capital Management Morristown, New Jersey $540M AUM 15.41% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

CX Institutional's INSM Position: Q3 2026 in Review

CX Institutional opened a new position in Insmed (INSM) in Q3 2026: 404 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #1028 among its holdings. This is a return to the name: CX Institutional previously reported a position in INSM as recently as Q1 2026.

CX Institutional first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • CX Institutional held 404 shares of Insmed worth $46K as of Q3 2026.
  • Insmed was a new CX Institutional position in Q3 2026.
  • Insmed made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1028 holding.
  • CX Institutional first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.